Be a part of the Solution
The US Cancer Problem
2+ million
New Cancer Cases
predicted for the year 2025.
2nd
Leading Cause
of deaths in the United States with over 600,000 predicted for 2025.
2.5x
Survivors
more likely to file bankruptcy.
Meet the Community
Member Organizations
Our members drive the success of CancerX, collaborating to set priorities and practices that will help us achieve our mission.
Advisory Leadership
Steering Committee
CancerX’s steering committee provides an additional layer of governance within CancerX’s public-private partnership model.
Xavier Avat, MBA, MBE
Chair of Steering Committee - EVP & Chief Business Officer at Moffitt Cancer Center
Jean Chai, MD
VP, Cancer Service Line NC/GA Division, Advocate Health
Stephen Konya
Chief, Innovation and Strategic Partnerships at ONC, U.S. Department of Health and Human Services (HHS).
Ashita S. Batavia, MD, MS
Global Head, Study Innovation,Global Medical Affairs at J&J innovative Medicine
Caroline Chung
VP & Chief Data &Analytics Officer, MD Anderson Cancer Center
Amina Ahmed
Director, Rush University Medical Center
Mark Tate
Executive Director, Oncology Portfolio, Novartis
Grace Cordovano, PhD, BCPA
CancerX Fellow, Founder & Board Certified Patient Advocate at Enlightening Results
Melissa Wheeler
Director Disparities & Outreach, Levine Cancer Institute
Jonathan George
Investor, Flare Capital Partners
Ben Freeberg
Founder and Managing Partner, Oncology Ventures
Baxter Lee
President, Clearwater
Craig A. Hunter
SVP, Oncology & Genetics, Carelon
